These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11600742)

  • 1. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis.
    Vittecoq O; Salle V; Jouen-Beades F; Krzanowska K; Ménard JF; Gayet A; Fardellone P; Tauveron P; Le Loët X; Tron F
    Rheumatology (Oxford); 2001 Oct; 40(10):1126-34. PubMed ID: 11600742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies recognizing the 27 carboxy-terminal amino acids of calpastatin are associated with secondary Sjögren syndrome in systemic lupus erythematosus.
    Salle V; Vittecoq O; Jouen-Beades F; Ménard JF; Ducroix JP; Godin M; Le Loët X; Tron F
    Lupus; 2004; 13(10):800-4. PubMed ID: 15540513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies directed against the amino-terminal domain I of human calpastatin (ACAST-DI Ab) in connective tissue diseases. High levels of ACAST-DI Ab are associated with vasculitis in lupus.
    Saulot V; Vittecoq O; Salle V; Drouot L; Legoedec J; Le Loët X; Godin M; Ducroix JP; Ménard JF; Tron F; Gilbert D
    J Autoimmun; 2002; 19(1-2):55-61. PubMed ID: 12367559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.
    Vittecoq O; Pouplin S; Krzanowska K; Jouen-Beades F; Menard JF; Gayet A; Daragon A; Tron F; Le Loet X
    Rheumatology (Oxford); 2003 Aug; 42(8):939-46. PubMed ID: 12730503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
    Mimori T; Suganuma K; Tanami Y; Nojima T; Matsumura M; Fujii T; Yoshizawa T; Suzuki K; Akizuki M
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7267-71. PubMed ID: 7638179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera.
    Lackner KJ; Schlosser U; Lang B; Schmitz G
    Br J Rheumatol; 1998 Nov; 37(11):1164-71. PubMed ID: 9851263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
    Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
    J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting].
    Takada R; Matsumoto M; Yosida M; Nojima T; Hirakata M; Ohosone Y; Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Aug; 21(4):150-8. PubMed ID: 9793376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
    Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
    Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
    Auger I; Roudier C; Guis S; Balandraud N; Roudier J
    Ann Rheum Dis; 2007 Dec; 66(12):1588-93. PubMed ID: 17324966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.
    Jouen F; Vittecoq O; Leguillou F; Tabti-Titon I; Menard JF; Mejjad O; Pouplin S; Boumier P; Fardellone P; Gayet A; Gilbert D; Tron F; Le Loët X
    Clin Exp Immunol; 2004 Sep; 137(3):606-11. PubMed ID: 15320914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance].
    Yasuoka H; Sugano Y; Oka T; Watanabe C; Kaneko Y; Nojima T; Matsumura M; Fujii T; Mimori T
    Ryumachi; 1997 Jun; 37(3):458-66. PubMed ID: 9256029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
    Xu J; Liu J; Zhu L; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):942-946. PubMed ID: 27987494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
    Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.
    Routsias JG; Tzioufas AG; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Clin Exp Immunol; 1993 Mar; 91(3):437-41. PubMed ID: 7680295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
    Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
    Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.